Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant administration of Boostrix, Gardasil, and MenACWY in healthy adolescents
2011-000476-34Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of acellular pertussis vaccine, qHPV vaccine and meningococcal A conjugate vaccine in meningococcal disease, human papillomavirus infection, diphtheria and 2 more (2 arms), sponsored by Novartis. Primary endpoints: Diphtheria seroprotection rate at 1 month after Tdap, Tetanus seroprotection rate at 1 month after Tdap and 6 more. Started Mar 2012; status: completed.
02
Drugs
acellular pertussis vaccineqHPV vaccinemeningococcal A conjugate vaccine
03
Conditions
meningococcal diseasehuman papillomavirus infectiondiphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2011-000476-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000476-34.